NM 283, an efficient prodrug of the potent anti-HCV agent 2′-C-methylcytidine

Nucleosides, Nucleotides and Nucleic Acids

Volumn 24, Issue 5-7, 2005, Pages 767-770

  Pierra, C ^a   Benzaria, S ^a   Amador, A ^b   Moussa, A ^c   Mathieu, S ^c   Storer, R ^b   Gosselin, G ^a  

^a CNRS   (France)

^b Laboratoire de Chimie Médicinale Idenix   (France)

^c Idenix Pharmaceuticals Inc   (United States)

Author keywords

2 C Methyl Branched Nucleosides; Hepatitis C Virus; Prodrugs

Indexed keywords

2' C METHYLCYTIDINE; 3' O VALINYL ESTER DERIVATIVE; ANTIVIRUS AGENT; ESTER DERIVATIVE; UNCLASSIFIED DRUG; VALOPICITABINE;

ANTIVIRAL ACTIVITY; CONFERENCE PAPER; DRUG POTENCY; DRUG SYNTHESIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PHYSICAL CHEMISTRY;

HEPATITIS C VIRUS;

EID: 26644455085     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1081/NCN-200060112     Document Type: Conference Paper

References (10)

1. Sommadossi, J.-P.; La Colla, P. Preparation of Antiviral Nucleosides and Methods for Treating Hepatitis C Virus; Novirio Pharmaceuticals Limited, Universita Degli Studi Di Cagliari, 2001.
2. Sommadossi, J.-P.; La Colla, P. Methods and Compositions Using Modified Nucleosides for Treating Flaviruses and Pestiviruses; Novirio Pharmaceuticals Limited, Universita Degli Studi Di Cagliari, 2001.
3. Harry-O'kuru, R.E.; Smith, J.M.; Wolfe, M.S. A short, flexible route toward 2′-C-branched ribonucleosides. J. Org. Chem. 1997, 62, 1754-1759.
4. Legorbu, U.; Reese, C.B.; Song, Q. Conversion of uridine into 2′-O-(2-methoxyethyl)uridine and 2′-O-(methoxyethyl)cytidine. Tetrahedron 1999, 55, 5635-5640.
5. 4-(Dialkylamino)methylene derivatives of 2′-deoxycytidine and arabinocytidine: physicochemical studies for potential prodrug applications. J. Pharm. Sci. 1994, 83, 582-586.
6. Ogilvie, K.K. The tert-butyldimethylsilyl group as a protecting group in deoxynucleosides. Can. J. Chem. 1973, 51, 3799-3807.
7. Dhaon, M.K.; Olsen, R.K.; Ramasamy, K. Esterification of N-protected α-amino acids with alcohol/carbodiimide/4-(dimethylamino)-pyridine. Racemisation of aspartic and glutamic acid derivatives. J. Org. Chem. 1982, 47, 1962-1965.
8. Zhang, W.; Robins, M.J. Removal of silyl protecting groups from hydroxyl functions with ammonium fluoride in methanol. Tetrahedron Lett. 1992, 33, 1177-1180.
9. Standring, D.N.; Lanford, R.; Wright, T.; Chung, R.T.; Bichko, V.; Cretton-Scott, E.; Pan-Zhou, X.; Bergelson, S.; Qu, L.; Tausek, M.; La Colla, M.; Anand, V.; Mao, J.; Bridges, E.G.; Moussa, A.; Chaudhuri, N.; Storer, D.; Pierra, C.; Benzaria, S.; Gosselin, G.; Shlaes, D.; La Colla, P.; Sommadossi, J.P. In NM 283 Has Potent Antiviral Activity Against Chronic Hepatitis C Virus Genotype-1 in the Chimpanzee, Abstract, HEP DART, Frontiers in Drug Development for Viral Hepatitis, Kauai, Hawaii, USA, December 14-18, 2003; 28.
10. Godofsky, E.; Afdhal, N.; Rustgi, V.; Duncan, L.; Zhou, X.J.; Chao, G.; Fang, C.; Fielman, B.; Myers, M.; Brown, N.A. In First Clinical Results for a Novel Antiviral Treatment for Hepatitis C: A Phase 1/11 Dose Escalation Trial Assessing Tolerance, Pharmacokinetics, and Antiviral Activity of NM 283, Abstract, 39th Annual Meeting of the European Association for the Study of the Liver (EASL), Berlin, Germany, April 14-18, 2004; 96.